Table of Content


Introduction
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Overview
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Therapeutics Development
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Therapeutics Assessment
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Companies Involved in Therapeutics Development
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Drug Profiles
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Dormant Products
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Discontinued Products
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development by Stage of Development, H1 2020
Number of Products under Development by Therapy Areas, H1 2020
Number of Products under Development by Top 10 Indications, H1 2020
Number of Products by Mechanism of Actions, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables


Number of Products under Development by Stage of Development, H1 2020
Number of Products under Development by Therapy Areas, H1 2020
Number of Products under Development by Indications, H1 2020
Number of Products under Development by Indications, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Indications, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1)
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Number of Products under Investigation by Universities/Institutes, H1 2020
Products under Investigation by Universities/Institutes, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Pipeline by AlzeCure Pharma AB, H1 2020
Pipeline by Amorepacific Corp, H1 2020
Pipeline by AntalGenics SL, H1 2020
Pipeline by Astellas Pharma Inc, H1 2020
Pipeline by Bsense Bio Therapeutics Ltd, H1 2020
Pipeline by Centrexion Therapeutics Corp, H1 2020
Pipeline by Cmxtwenty, H1 2020
Pipeline by Concentric Analgesics Inc, H1 2020
Pipeline by GB Sciences Inc, H1 2020
Pipeline by GBSciences Inc, H1 2020
Pipeline by Grunenthal GmbH, H1 2020
Pipeline by GW Pharmaceuticals Plc, H1 2020
Pipeline by Interventional Analgesix Inc, H1 2020
Pipeline by Ion Channel Pharmacology LLC, H1 2020
Pipeline by Jeil Pharmaceutical Co Ltd, H1 2020
Pipeline by Medifron DBT Co Ltd, H1 2020
Pipeline by Mestex AG, H1 2020
Pipeline by Neurim Pharmaceuticals Ltd, H1 2020
Pipeline by Novartis AG, H1 2020
Pipeline by Oblique Therapeutics AB, H1 2020
Pipeline by Pila Pharma AB, H1 2020
Pipeline by Revive Therapeutics Ltd, H1 2020
Pipeline by Scopus BioPharma Inc, H1 2020
Pipeline by Serentrix LLC, H1 2020
Pipeline by Sorrento Therapeutics Inc, H1 2020
Pipeline by Sylentis SAU, H1 2020
Pipeline by Vitality Biopharma Inc, H1 2020
Pipeline by Winston Pharmaceuticals Inc, H1 2020
Pipeline by Young BioPharma LLC, H1 2020
Dormant Products, H1 2020
Dormant Products, H1 2020 (Contd..1), H1 2020
Dormant Products, H1 2020 (Contd..2), H1 2020
Dormant Products, H1 2020 (Contd..3), H1 2020
Dormant Products, H1 2020 (Contd..4), H1 2020
Dormant Products, H1 2020 (Contd..5), H1 2020
Dormant Products, H1 2020 (Contd..6), H1 2020
Discontinued Products, H1 2020
Discontinued Products, H1 2020 (Contd..1), H1 2020